Form D · Biotechnology
Nu-Tek BioSciences, LLC
Minnetonka, MN · CIK 0001982335
Offering snapshot reported Jun 21, 2023 · SEC filing
- Reported sold
- $1.68M Offering amount: $3M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- May 4, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 21, 2023 | Initial | $1,680,000 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-484734
Source: Form D, filed Jun 21, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kent Mc Coy | Executive |
| Thomas L. Yezzi | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5400 Opportunity Court Suite 120
Minnetonka, MN, 55343
Minnetonka, MN, 55343